Crit Care:院外心脏骤停患者心肺复苏期间被动抬腿的临床结局和安全性

2021-05-25 MedSci原创 MedSci原创

CPR期间PLR治疗并不能提高患者出院的存活率。

有数据表明,被动抬腿(PLR)可改善心肺复苏(CPR)期间的血液动力学。近日,危重病医学领域权威杂志Critical Care上发表了一篇研究文章,该研究旨在明确心肺复苏期间PLR在院外心脏骤停(OHCA)患者中的疗效和安全性。

研究人员进行了一项随机对照试验,对结局进行了盲法评估,OHCA成人被分配接受PLR或平躺。该研究的主要终点为出院后的生存率、神经功能良好,即为脑功能类别(CPC为1-2)。为了探究可能的不良反应,研究人员评估了幸存者首次胸部X光检查、计算机断层扫描(CT)上是否存在肺部并发症,以及非幸存者的尸检中脑和肺的重量。

该研究总共纳入了588例随机病例,其中301例接受了PLR治疗,而287例为对照。总体而言,男性为67.8%,中位年龄为72(IQR为60-82)岁。出院时,PLC组中3.3%的患者和3.5%的对照者CPC为1–2(OR为0.9;95%CI为0.4–2.3,p=0.91)。

生存率结局

所有患者(OR为1.0;95%CI为0.7-1.6,p=0.95)和初始电击性节律患者(OR为1.7;95%CI为0.8-3.4,p=0.15)入院时的生存率均无显著差异。胸部X光检查的肺部并发症发生率[7(25.9%)vs. 5(17.9%),p=0.47]和脑水肿在CT上无显著差异[5(29.4%)vs 10(32.6%),p=0.84]。106次尸检中发现肺部重量[1223 mg(IQR为909–1500)与1239 mg(IQR为900–1507),p=0.82]或脑部重量[1352 mg(IQR为1227–1457)与1380 mg(IQR为1255–1470),p=0.43]无差异。

由此可见,CPR期间PLR治疗并不能提高患者出院的存活率

原始出处:

Youcef Azeli.et al.Clinical outcomes and safety of passive leg raising in out-of-hospital cardiac arrest: a randomized controlled trial.Critical Care.2021.https://ccforum.biomedcentral.com/articles/10.1186/s13054-021-03593-7

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1684575, encodeId=bfec16845e500, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Mon Sep 20 02:17:23 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843257, encodeId=908c184325e3e, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Oct 31 17:17:23 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971988, encodeId=162c9e1988de, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/6f761c3f7c2047bbad5d471e013dae28/96525bc5bb034d7c814663c3f9c553fa.jpg, createdBy=85c65507801, createdName=梨4, createdTime=Tue Jun 08 22:01:53 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305522, encodeId=10d7130552207, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Thu May 27 14:17:23 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305678, encodeId=bd9413056e812, content=<a href='/topic/show?id=1787983537c' target=_blank style='color:#2F92EE;'>#院外心脏骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98353, encryptionId=1787983537c, topicName=院外心脏骤停)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Thu May 27 14:17:23 CST 2021, time=2021-05-27, status=1, ipAttribution=)]
    2021-09-20 aids222
  2. [GetPortalCommentsPageByObjectIdResponse(id=1684575, encodeId=bfec16845e500, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Mon Sep 20 02:17:23 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843257, encodeId=908c184325e3e, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Oct 31 17:17:23 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971988, encodeId=162c9e1988de, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/6f761c3f7c2047bbad5d471e013dae28/96525bc5bb034d7c814663c3f9c553fa.jpg, createdBy=85c65507801, createdName=梨4, createdTime=Tue Jun 08 22:01:53 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305522, encodeId=10d7130552207, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Thu May 27 14:17:23 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305678, encodeId=bd9413056e812, content=<a href='/topic/show?id=1787983537c' target=_blank style='color:#2F92EE;'>#院外心脏骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98353, encryptionId=1787983537c, topicName=院外心脏骤停)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Thu May 27 14:17:23 CST 2021, time=2021-05-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1684575, encodeId=bfec16845e500, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Mon Sep 20 02:17:23 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843257, encodeId=908c184325e3e, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Oct 31 17:17:23 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971988, encodeId=162c9e1988de, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/6f761c3f7c2047bbad5d471e013dae28/96525bc5bb034d7c814663c3f9c553fa.jpg, createdBy=85c65507801, createdName=梨4, createdTime=Tue Jun 08 22:01:53 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305522, encodeId=10d7130552207, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Thu May 27 14:17:23 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305678, encodeId=bd9413056e812, content=<a href='/topic/show?id=1787983537c' target=_blank style='color:#2F92EE;'>#院外心脏骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98353, encryptionId=1787983537c, topicName=院外心脏骤停)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Thu May 27 14:17:23 CST 2021, time=2021-05-27, status=1, ipAttribution=)]
    2021-06-08 梨4

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1684575, encodeId=bfec16845e500, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Mon Sep 20 02:17:23 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843257, encodeId=908c184325e3e, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Oct 31 17:17:23 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971988, encodeId=162c9e1988de, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/6f761c3f7c2047bbad5d471e013dae28/96525bc5bb034d7c814663c3f9c553fa.jpg, createdBy=85c65507801, createdName=梨4, createdTime=Tue Jun 08 22:01:53 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305522, encodeId=10d7130552207, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Thu May 27 14:17:23 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305678, encodeId=bd9413056e812, content=<a href='/topic/show?id=1787983537c' target=_blank style='color:#2F92EE;'>#院外心脏骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98353, encryptionId=1787983537c, topicName=院外心脏骤停)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Thu May 27 14:17:23 CST 2021, time=2021-05-27, status=1, ipAttribution=)]
    2021-05-27 lizhou0204
  5. [GetPortalCommentsPageByObjectIdResponse(id=1684575, encodeId=bfec16845e500, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Mon Sep 20 02:17:23 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843257, encodeId=908c184325e3e, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Oct 31 17:17:23 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971988, encodeId=162c9e1988de, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/6f761c3f7c2047bbad5d471e013dae28/96525bc5bb034d7c814663c3f9c553fa.jpg, createdBy=85c65507801, createdName=梨4, createdTime=Tue Jun 08 22:01:53 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305522, encodeId=10d7130552207, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Thu May 27 14:17:23 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305678, encodeId=bd9413056e812, content=<a href='/topic/show?id=1787983537c' target=_blank style='color:#2F92EE;'>#院外心脏骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98353, encryptionId=1787983537c, topicName=院外心脏骤停)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b96f328, createdName=wwzzly, createdTime=Thu May 27 14:17:23 CST 2021, time=2021-05-27, status=1, ipAttribution=)]

相关威廉亚洲官网

Stroke:辣椒素对脑灌注影响和安全性分析

该研究提供了辣椒素在健康志愿者人群中安全性和耐受性的证据。辣椒素似乎可以获得与蝶腭神经节电刺激相似的效应。

BMJ:covid-19疫苗安全问题将如何影响疫苗信心?

认识到不确定性和安全恐惧,通过可信的信息与公众对话,以及迅速和基于科学的方案反应,继续建立和维持信任。

中国科兴新冠疫苗智利Ⅲ期试验初步结果显示良好安全性和免疫原性

智利有关专家团队17日在圣地亚哥举行发布会,介绍了去年11月以来中国科兴公司新冠疫苗在智利进行Ⅲ期临床试验的初步情况,证实科兴疫苗具有良好的安全性和免疫原性。

The Oncologist:Palbociclib联合内分泌治疗HR+/HER2-转移性乳腺癌的安全性分析:来自PALOMA系列5年随访综合分析更新

通过5年的长期综合分析,证实Palbociclib联合内分泌治疗HR+/HER2-转移性乳腺癌是一种安全的治疗方式。

JCEM:热消融治疗原发性甲状旁腺功能亢进的疗效和安全性分析

近日,内分泌和代谢性疾病领域权威杂志Journal of Clinical Endocrinology & Metabolism上发表了一篇研究文章,这项研究旨评估热消融治疗原发性甲状旁腺功能

文献解读:含利多卡因的瑞蓝临床研究—医生与求美者的福音

越来越多的整形外科医生把目光聚集在非手术治疗的领域,虽说是非手术治疗,许多求美者因为惧怕注射带来的疼痛感而对注射类的美容治疗望而生畏。一项调研数据显示